메뉴 건너뛰기




Volumn 6, Issue 4, 2013, Pages 825-832

Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure

Author keywords

Heart failure; Mineralocorticoid receptor antagonism; Urocortins

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CANRENOIC ACID; CREATININE; POTASSIUM; UROCORTIN II; VASOPRESSIN; ADRENALIN; CANRENOATE POTASSIUM; HYDROCORTISONE; MINERALOCORTICOID ANTAGONIST; NORADRENALIN; SODIUM; UROCORTIN;

EID: 84884708605     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000205     Document Type: Article
Times cited : (13)

References (45)
  • 1
    • 77951879058 scopus 로고    scopus 로고
    • Aldosterone: Effects on the kidney and cardiovascular system
    • Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6:261-273.
    • (2010) Nat Rev Nephrol , vol.6 , pp. 261-273
    • Briet, M.1    Schiffrin, E.L.2
  • 2
    • 81855183776 scopus 로고    scopus 로고
    • Mineralocorticoid receptor antagonists for heart failure
    • Richards AM. Mineralocorticoid receptor antagonists for heart failure. Expert Opin Pharmacother. 2011;12:2801-2815.
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 2801-2815
    • Richards, A.M.1
  • 3
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 4
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
    • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.
    • (2003) N Engl J Med , vol.348 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3    Neaton, J.4    Martinez, F.5    Roniker, B.6    Bittman, R.7    Hurley, S.8    Kleiman, J.9    Gatlin, M.10
  • 7
    • 77954056940 scopus 로고    scopus 로고
    • Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: Current status
    • Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010;160:1273-1292.
    • (2010) Br J Pharmacol , vol.160 , pp. 1273-1292
    • Ma, T.K.1    Kam, K.K.2    Yan, B.P.3    Lam, Y.Y.4
  • 8
    • 0000432665 scopus 로고    scopus 로고
    • Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor
    • Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 2001;7:605-611.
    • (2001) Nat Med , vol.7 , pp. 605-611
    • Hsu, S.Y.1    Hsueh, A.J.2
  • 9
    • 7444272894 scopus 로고    scopus 로고
    • CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators
    • Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol. 2004;143:508-514.
    • (2004) Br J Pharmacol , vol.143 , pp. 508-514
    • Wiley, K.E.1    Davenport, A.P.2
  • 12
    • 33644877288 scopus 로고    scopus 로고
    • Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: Beneficial effects in heart failure
    • Rademaker MT, Cameron VA, Charles CJ, Richards AM. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation. 2005;112:3624-3632.
    • (2005) Circulation , vol.112 , pp. 3624-3632
    • Rademaker, M.T.1    Cameron, V.A.2    Charles, C.J.3    Richards, A.M.4
  • 13
    • 42549101298 scopus 로고    scopus 로고
    • Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure
    • Rademaker MT, Charles CJ, Nicholls MG, Richards AM. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Clin Sci (Lond). 2008;114:635-642.
    • (2008) Clin Sci (Lond) , vol.114 , pp. 635-642
    • Rademaker, M.T.1    Charles, C.J.2    Nicholls, M.G.3    Richards, A.M.4
  • 14
    • 77952521665 scopus 로고    scopus 로고
    • Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure
    • Rademaker MT, Charles CJ, Nicholls MG, Richards AM. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. Circ Heart Fail. 2009;2:532-540.
    • (2009) Circ Heart Fail , vol.2 , pp. 532-540
    • Rademaker, M.T.1    Charles, C.J.2    Nicholls, M.G.3    Richards, A.M.4
  • 15
    • 79956337356 scopus 로고    scopus 로고
    • Prolonged urocortin 2 administration in experimental heart failure: Sustained hemodynamic, endocrine, and renal effects
    • Rademaker MT, Charles CJ, Ellmers LJ, Lewis LK, Nicholls MG, Richards AM. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects. Hypertension. 2011;57:1136-1144.
    • (2011) Hypertension , vol.57 , pp. 1136-1144
    • Rademaker, M.T.1    Charles, C.J.2    Ellmers, L.J.3    Lewis, L.K.4    Nicholls, M.G.5    Richards, A.M.6
  • 18
    • 33644799148 scopus 로고    scopus 로고
    • Effects of intravenous urocortin on angiotensin-converting enzyme in rats
    • Yang C, Xu Y, Mendez T, Wang F, Yang Q, Li S. Effects of intravenous urocortin on angiotensin-converting enzyme in rats. Vascul Pharmacol. 2006;44:238-246.
    • (2006) Vascul Pharmacol , vol.44 , pp. 238-246
    • Yang, C.1    Xu, Y.2    Mendez, T.3    Wang, F.4    Yang, Q.5    Li, S.6
  • 19
    • 26444456075 scopus 로고    scopus 로고
    • Endogenous urocortins reduce vascular tone and reninaldosterone/ endothelin activity in experimental heart failure
    • Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Lainchbury JG, Richards AM. Endogenous urocortins reduce vascular tone and reninaldosterone/ endothelin activity in experimental heart failure. Eur Heart J. 2005;26:2046-2054.
    • (2005) Eur Heart J , vol.26 , pp. 2046-2054
    • Rademaker, M.T.1    Charles, C.J.2    Espiner, E.A.3    Frampton, C.M.4    Lainchbury, J.G.5    Richards, A.M.6
  • 23
    • 0031975483 scopus 로고    scopus 로고
    • Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: Role of natriuretic peptides and angiotensin II
    • Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. J Cardiovasc Pharmacol. 1998;31:116-125.
    • (1998) J Cardiovasc Pharmacol , vol.31 , pp. 116-125
    • Rademaker, M.T.1    Charles, C.J.2    Espiner, E.A.3    Nicholls, M.G.4    Richards, A.M.5    Kosoglou, T.6
  • 25
    • 4744368848 scopus 로고    scopus 로고
    • Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs
    • Gudmundsson FF, Viste A, Myking OL, Grong K, Svanes K. Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs. Surg Endosc. 2004;18:1528-1534.
    • (2004) Surg Endosc , vol.18 , pp. 1528-1534
    • Gudmundsson, F.F.1    Viste, A.2    Myking, O.L.3    Grong, K.4    Svanes, K.5
  • 26
    • 0022133564 scopus 로고
    • Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep
    • Rabinowitz L, Sarason RL, Yamauchi H. Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep. Am J Physiol. 1985;249(4 Pt 2):R455-R461.
    • (1985) Am J Physiol , vol.249 , Issue.4 PART 2
    • Rabinowitz, L.1    Sarason, R.L.2    Yamauchi, H.3
  • 27
    • 0027427833 scopus 로고
    • Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans
    • van Buren M, Boer P, Koomans HA. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans. J Clin Endocrinol Metab. 1993;77:902-909.
    • (1993) J Clin Endocrinol Metab , vol.77 , pp. 902-909
    • Van Buren, M.1    Boer, P.2    Koomans, H.A.3
  • 29
    • 71249092636 scopus 로고    scopus 로고
    • Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: Disruption of an endogenous inhibitor of angiogenesis and proliferation
    • Tezval H, Jurk S, Atschekzei F, Becker JU, Jahn O, Serth J, Kuczyk MA. Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation. World J Urol. 2009;27:825-830.
    • (2009) World J Urol , vol.27 , pp. 825-830
    • Tezval, H.1    Jurk, S.2    Atschekzei, F.3    Becker, J.U.4    Jahn, O.5    Serth, J.6    Kuczyk, M.A.7
  • 31
    • 70350336006 scopus 로고    scopus 로고
    • Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF
    • Li X, Hu J, Zhang Q, Sun X, Li S. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF. Br J Pharmacol. 2009;157:994-1003.
    • (2009) Br J Pharmacol , vol.157 , pp. 994-1003
    • Li, X.1    Hu, J.2    Zhang, Q.3    Sun, X.4    Li, S.5
  • 33
    • 0023678639 scopus 로고
    • Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems
    • Lahera V, Cachofeiro V, Duran F, Cañizo FJ, Rodriguez FJ, Tresguerres JA. Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems. Gen Pharmacol. 1988;19:835-839.
    • (1988) Gen Pharmacol , vol.19 , pp. 835-839
    • Lahera, V.1    Cachofeiro, V.2    Duran, F.3    Cañizo, F.J.4    Rodriguez, F.J.5    Tresguerres, J.A.6
  • 34
    • 79952142761 scopus 로고    scopus 로고
    • Differential effects of mineralocorticoid blockade on the hypothalamo-pituitary-adrenal axis in pregnant and nonpregnant ewes
    • Lingis M, Richards EM, Keller-Wood M. Differential effects of mineralocorticoid blockade on the hypothalamo-pituitary-adrenal axis in pregnant and nonpregnant ewes. Am J Physiol Endocrinol Metab. 2011;300:E592-E599.
    • (2011) Am J Physiol Endocrinol Metab , vol.300
    • Lingis, M.1    Richards, E.M.2    Keller-Wood, M.3
  • 35
    • 75149173528 scopus 로고    scopus 로고
    • Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep
    • Charles CJ, Jardine DL, Rademaker MT, Richards AM. Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep. J Endocrinol. 2010;204:181-189.
    • (2010) J Endocrinol , vol.204 , pp. 181-189
    • Charles, C.J.1    Jardine, D.L.2    Rademaker, M.T.3    Richards, A.M.4
  • 36
    • 58849164929 scopus 로고    scopus 로고
    • Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats
    • Hlavacova N, Jezova D. Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats. Endocr Regul. 2008;42:147-153.
    • (2008) Endocr Regul , vol.42 , pp. 147-153
    • Hlavacova, N.1    Jezova, D.2
  • 37
    • 79957821827 scopus 로고    scopus 로고
    • Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland
    • Squillacioti C, De Luca A, Liguori G, Paino S, Mirabella N. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland. Gen Comp Endocrinol. 2011;172:416-422.
    • (2011) Gen Comp Endocrinol , vol.172 , pp. 416-422
    • Squillacioti, C.1    De Luca, A.2    Liguori, G.3    Paino, S.4    Mirabella, N.5
  • 38
    • 84855642277 scopus 로고    scopus 로고
    • Non-genomic actions of aldosterone: From receptors and signals to membrane targets
    • Dooley R, Harvey BJ, Thomas W. Non-genomic actions of aldosterone: from receptors and signals to membrane targets. Mol Cell Endocrinol. 2012;350:223-234.
    • (2012) Mol Cell Endocrinol , vol.350 , pp. 223-234
    • Dooley, R.1    Harvey, B.J.2    Thomas, W.3
  • 40
    • 6344288979 scopus 로고    scopus 로고
    • Elevated resting and exercise- induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans
    • Wellhoener P, Born J, Fehm HL, Dodt C. Elevated resting and exercise- induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J Clin Endocrinol Metab. 2004;89:5048-5052.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5048-5052
    • Wellhoener, P.1    Born, J.2    Fehm, H.L.3    Dodt, C.4
  • 41
    • 0035076428 scopus 로고    scopus 로고
    • Physiological roles of corticotropin-releasing hormone receptor type 2
    • Hashimoto K, Makino S, Asaba K, Nishiyama M. Physiological roles of corticotropin-releasing hormone receptor type 2. Endocr J. 2001;48:1-9.
    • (2001) Endocr J , vol.48 , pp. 1-9
    • Hashimoto, K.1    Makino, S.2    Asaba, K.3    Nishiyama, M.4
  • 44
    • 33646695467 scopus 로고    scopus 로고
    • Urocortin II improves calcium handling and contractility in isolated cardiac myocytes from wild-type and muscle LIM protein knock-out mice
    • Dieterle T, Belke DD, Hoshijima M, Chien KR, Bale T, Vale WW, Dillmann WH, Perterson KL. Urocortin II improves calcium handling and contractility in isolated cardiac myocytes from wild-type and muscle LIM protein knock-out mice. Circulation. 2003;108(suppl IV):341.
    • (2003) Circulation , vol.108 , Issue.SUPPL. IV , pp. 341
    • Dieterle, T.1    Belke, D.D.2    Hoshijima, M.3    Chien, K.R.4    Bale, T.5    Vale, W.W.6    Dillmann, W.H.7    Perterson, K.L.8
  • 45
    • 14644388102 scopus 로고    scopus 로고
    • Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats
    • Abdelrahman AM, Lin Lim S, Pang CC. Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats. Eur J Pharmacol. 2005;510:107-111.
    • (2005) Eur J Pharmacol , vol.510 , pp. 107-111
    • Abdelrahman, A.M.1    Lin Lim, S.2    Pang, C.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.